HWI pharma services
HWI pharma services is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-controlled, double-blind, combined dose-finding and proof-of-concept trial with parallel-group design in postmenopausal women
Sponsor SocraTec R&D Concepts in Drug Research and Development GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A mono-centre, non-comparative clinical trial on the inhibition of ovulation with LNG POP (Levonorgestrel tablet, 0.135 mg) during three 28-day cycles with continuous treatment and intentional intake errors
Sponsor SocraTec R&D Concepts in Drug Research and Development GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, double-blind, randomized, placebo-controlled, dose-response trial with the full-spectrum Cannabis Extract VER-01 in patients with chronic non-specific low back pain
Sponsor Vertanical GmbH
- Start (EU)
- Latest update
- Estimated end
Efficacy and tolerability of horse chestnut seed extract on swelling in patients undergoing meniscus surgery: a placebo-controlled, randomized, double-blind, single-center, pilot study
Sponsor Cesra Arzneimittel GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for HWI pharma services?
The 2026-10-09 snapshot links HWI pharma services to 4 distinct CTIS trials. Recorded services include EudraVigilance Responsible Person, IMP packaging, labelling, QP certification, Medicinal product management, Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for HWI pharma services?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to HWI pharma services conducted?
The linked trials record locations in 4 countries, including Germany, Czechia, Spain, Poland. These are trial locations, not confirmed office locations or countries where HWI pharma services delivered services.
What can this page tell me about HWI pharma services's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under HWI pharma services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- HWI Pharma Services GmbH
- HWI pharma services GmbH